Search

Michelle R Arkin

from Greensboro, NC
Age ~56
Get Report
Also known as:
Michelle Rose Arkin
Related to:
Tina Marie Beggs, 69
Connected to:
Anna I Arkin, 36Hannah P Arkin, 44Janna L Arkin, 46Jason D Arkin, 48Judy F Arkin, 80Julie A Arkin, 66Lori C Arkin, 66Madeline R Arkin, 37Pamela A Arkin, 71Sandra I Arkin, 76

Michelle Arkin Phones & Addresses

  • Greensboro, NC
  • 777 Faxon Ave, San Francisco, CA 94112 (415) 334-9856
  • 145 Jersey St, San Francisco, CA 94114 (415) 643-5593
  • South San Francisco, CA
  • Pasadena, CA
  • 145 Jersey St, San Francisco, CA 94114 (415) 812-6927

Work

Position: Construction and Extraction Occupations

Education

Degree: High school graduate or higher

Industries

Pharmaceuticals

Resumes

Resumes

Michelle Arkin Photo 1

Michelle Arkin

View page
Location:
San Francisco Bay Area
Industry:
Pharmaceuticals

Publications

Us Patents

Therapeutic Combinations Comprising (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid

View page
US Patent:
7968565, Jun 28, 2011
Filed:
Mar 14, 2005
Appl. No.:
11/080102
Inventors:
Michelle Arkin - San Francisco CA, US
Jennifer Hyde - San Francisco CA, US
Duncan Walker - Moss Beach CA, US
Jasmin Wright - San Francsico CA, US
Assignee:
Sunesis Pharmaceuticals, Inc. - So. San Francisco CA
International Classification:
A61K 31/47
A61K 31/70
US Classification:
514300, 514 49
Abstract:
The present invention relates to SNS-595 and methods of treating cancer using the same.

Small-Molecule Inhibitors Of Interleukin-2

View page
US Patent:
20030149049, Aug 7, 2003
Filed:
Dec 17, 2001
Appl. No.:
10/024665
Inventors:
Michelle Arkin - San Francisco CA, US
Robert McDowell - San Francisco CA, US
Johan Oslob - Sunnyvale CA, US
Brian Raimundo - San Francisco CA, US
Nathan Waal - San Francisco CA, US
Chul Yu - San Francisco CA, US
International Classification:
A61K031/506
A61K031/496
A61K031/454
A61K031/4439
A61K031/427
A61K031/422
A61K031/4178
A61K031/4184
C 07D 4 3/02
C 07D 4 3/14
US Classification:
514/254050, 514/326000, 544/371000, 546/211000, 514/256000, 514/341000, 514/397000, 514/394000, 514/365000, 514/374000, 544/331000, 548/191000, 548/222000, 548/305400, 548/312400
Abstract:
Compounds of formulae I and I′, methods of making them, pharmaceutical compositions containing them, and methods for their use. The compounds are antagonists of IL-2/IL-2R binding; and are useful for the treatment of interleukin-2 mediated diseases, such as autoimmune diseases (such as rheumatoid arthritis, multiple sclerosis, uveitis, and psoriasis), allograft rejection, and graft-versus-host disease.

Surface Plasmon Resonance Methods

View page
US Patent:
20030186464, Oct 2, 2003
Filed:
Jan 29, 2003
Appl. No.:
10/354899
Inventors:
Michelle Arkin - San Francisco CA, US
Jennifer Hyde - San Francisco CA, US
Brian Cunningham - San Mateo CA, US
International Classification:
G01N033/543
US Classification:
436/518000
Abstract:
The present invention relates to the use of SPR methods to obtain information relating to molecular binding events. In one aspect of the present invention, methods are provided for determining whether a binding interaction is competitive or cooperative. In another aspect of the present invention, methods are provided for obtaining information where the binding interaction includes a formation of a reversible covalent bond.

Methods Of Characterizing Molecular Interaction Sites On Proteins

View page
US Patent:
20030235862, Dec 25, 2003
Filed:
Apr 4, 2003
Appl. No.:
10/407416
Inventors:
Michelle Arkin - San Francisco CA, US
Brian Cunningham - San Mateo CA, US
Warren DeLano - San Carlos CA, US
Raymond Fucini - San Bruno CA, US
International Classification:
G01N033/53
G01N033/543
US Classification:
435/007100, 436/518000
Abstract:
The present invention is directed to methods of characterizing molecular interaction sites on a biological target molecule. The methods involve contacting a polypeptide with a library of ligand candidates each of which is capable of tethering to the polypeptide at a site of interest, and analyzing the physicochemical properties of the ligand candidates tethering to the polypeptide. The methods herein are useful for discovery of and development of small molecule drugs.

Sns-595 And Methods Of Using The Same

View page
US Patent:
20060063795, Mar 23, 2006
Filed:
Sep 2, 2005
Appl. No.:
11/218653
Inventors:
Michelle Arkin - San Francisco CA, US
Jennifer Hyde - San Francisco CA, US
Duncan Walker - Moss Beach CA, US
Jasmin Wright - San Francisco CA, US
International Classification:
A61K 31/4745
C12Q 1/68
US Classification:
514300000, 435006000
Abstract:
The present invention relates to SNS-595 and methods of treating cancer using the same.

Methods Of Using(+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4 -Oxo-1-(2-Thiazolyl)- 1,8-Naphthyridine-3-Carboxylic Acid For Treatment Of Cancer

View page
US Patent:
20090263393, Oct 22, 2009
Filed:
Sep 5, 2006
Appl. No.:
11/991349
Inventors:
Daniel C. Adelman - Redwood City CA, US
Jeffrey A. Silverman - Burlingame CA, US
Michelle Arkin - San Francisco CA, US
Jennifer Hyde - Bend OR, US
Duncan Walker - Boulder CO, US
Jasmine Wright - San Francisco CA, US
International Classification:
A61K 39/395
A61K 31/4375
A61P 35/02
C07D 471/04
A61K 31/513
US Classification:
4241381, 514300, 4241741, 546123, 514274
Abstract:
Methods of treating, preventing or managing cancer, including certain leukemias are disclosed. The methods encompass the administration of enantiomerically pure (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods are also disclosed.

Sns-595 And Methods Of Using The Same

View page
US Patent:
20110263524, Oct 27, 2011
Filed:
Apr 27, 2011
Appl. No.:
13/095111
Inventors:
Michelle Arkin - San Francisco CA, US
Jennifer Hyde - San Francisco CA, US
Duncan Walker - Moss Beach CA, US
Jasmin Wright - San Francisco CA, US
International Classification:
A61K 31/7068
A61P 35/02
A61P 35/00
US Classification:
514 49
Abstract:
The present invention relates to SNS-595 and methods of treating cancer using the same.

Sns-595 And Methods Of Using The Same

View page
US Patent:
20130244967, Sep 19, 2013
Filed:
Mar 11, 2013
Appl. No.:
13/794583
Inventors:
MICHELLE ARKIN - San Francisco CA, US
JENNIFER HYDE - San Francisco CA, US
DUNCAN WALKER - Moss Beach CA, US
JASMIN WRIGHT - San Francisco CA, US
Assignee:
Sunesis Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07D 471/04
A61K 31/4375
A61K 31/7068
US Classification:
514 49
Abstract:
The present invention relates to SNS-595 and methods of treating cancer using the same.
Control profile
Michelle R Arkin from Greensboro, NC, age ~56 Get Report